Cell MedX Corp (CMXC)
0.03
+0.01
(+36.36%)
USD |
OTCM |
May 03, 16:00
Cell MedX Max Drawdown (5Y): 99.60% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 99.60% |
| March 31, 2024 | 99.60% |
| February 29, 2024 | 99.60% |
| January 31, 2024 | 99.60% |
| December 31, 2023 | 99.60% |
| November 30, 2023 | 99.57% |
| October 31, 2023 | 99.57% |
| September 30, 2023 | 99.57% |
| August 31, 2023 | 99.57% |
| July 31, 2023 | 99.57% |
| June 30, 2023 | 99.26% |
| May 31, 2023 | 98.71% |
| April 30, 2023 | 98.71% |
| March 31, 2023 | 98.71% |
| February 28, 2023 | 98.71% |
| January 31, 2023 | 98.71% |
| December 31, 2022 | 98.71% |
| November 30, 2022 | 97.94% |
| October 31, 2022 | 96.63% |
| September 30, 2022 | 96.56% |
| August 31, 2022 | 96.56% |
| July 31, 2022 | 96.56% |
| June 30, 2022 | 96.56% |
| May 31, 2022 | 93.86% |
| April 30, 2022 | 93.31% |
| Date | Value |
|---|---|
| March 31, 2022 | 93.25% |
| February 28, 2022 | 93.19% |
| January 31, 2022 | 93.19% |
| December 31, 2021 | 93.19% |
| November 30, 2021 | 93.19% |
| October 31, 2021 | 91.17% |
| September 30, 2021 | 89.02% |
| August 31, 2021 | 89.02% |
| July 31, 2021 | 89.02% |
| June 30, 2021 | 89.02% |
| May 31, 2021 | 89.02% |
| April 30, 2021 | 89.02% |
| March 31, 2021 | 89.02% |
| February 28, 2021 | 89.02% |
| January 31, 2021 | 89.02% |
| December 31, 2020 | 89.02% |
| November 30, 2020 | 89.02% |
| October 31, 2020 | 89.02% |
| September 30, 2020 | 89.02% |
| August 31, 2020 | 89.02% |
| July 31, 2020 | 89.02% |
| June 30, 2020 | 89.02% |
| May 31, 2020 | 89.02% |
| April 30, 2020 | 89.02% |
| March 31, 2020 | 89.02% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
82.22%
Minimum
May 2019
99.60%
Maximum
Dec 2023
92.44%
Average
92.18%
Median
Max Drawdown (5Y) Benchmarks
| Perspective Therapeutics Inc | 91.70% |
| Electromed Inc | 55.84% |
| Xtant Medical Holdings Inc | 98.66% |
| Asensus Surgical Inc | 99.68% |
| Senseonics Holdings Inc | 92.82% |